
Loading, please wait...

Loading, please wait...

Researchers recently investigated the knowledge, attitudes, and practices (KAP) of high-risk individuals regarding obstructive sleep apnea management. Although many participants demonstrated a foundational understanding of the condition, a significant disparity remains between patient knowledge and symptom management. Specifically, participants scored well on knowledge, yet only 25.95% reached the practice threshold.
The study identified several critical factors that influence health outcomes. Older age and lower household income independently correlated with lower practice scores. Conversely, higher educational attainment positively influenced knowledge levels. Furthermore, structural equation modeling showed that while knowledge fosters positive attitudes, it does not automatically ensure better health practices. Consequently, clinical interventions must address barriers like affordability and self-efficacy instead of relying solely on education. In India, the INOSA guidelines emphasize the importance of comprehensive sleep evaluation for high-risk patients with obesity or hypertension.
Additionally, clinicians should prioritize streamlining the referral process for polysomnography. Improving access to positive airway pressure (PAP) therapy is also essential for effective long-term care.
Knowledge alone is often insufficient to change health behaviors. Barriers such as the high cost of diagnosis, lack of access to specialized clinics, and low patient self-efficacy often hinder the transition from understanding OSA to actively managing it.
High-risk groups include individuals with obesity, hypertension, diabetes, and those of advanced age. Clinical guidelines recommend that these patients undergo comprehensive sleep evaluations if they present with snoring or daytime sleepiness.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Wu Y et al. Knowledge, attitudes, and practices toward obstructive sleep apnea among high-risk populations. BMC Public Health. 2026 Feb 17. doi: 10.1186/s12889-026-26683-z. PMID: 41703528.
Sharma SK, et al. Consensus and evidence-based Indian initiative on obstructive sleep apnea guidelines 2014 (first edition). Lung India. 2015;32(Suppl S4):422-34.
Khan AF. Obstructive Sleep Apnea In An Indian Population: A Cross Sectional Study. Int J Med Stud. 2023;11(4):275-281.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study on high-risk populations highlights a gap between OSA knowledge and practice, emphasizing the need for interventions beyond education....
5 months ago

New toxicological research evaluates heavy metal contamination in encapsulated green tea supplements, revealing that lead intake can exceed permitted daily exposure limits. The findings highlight the critical need for exposure-based risk assessment in botanical formulations.
Today

A prospective study evaluates the fetal Evans Index in late-onset fetal growth restriction, uncovering anterior cerebral remodeling rather than ventriculomegaly, with conventional growth metrics retaining primary prognostic power for neonatal intensive care unit admission.
Today

Following the admission of Union Health Minister JP Nadda to AIIMS Delhi for acute uneasiness, clinical teams utilized diagnostic coronary angiography and inpatient observation. This clinical review outlines acute triage pathways, procedural protocols, post-procedure observation, and long-term risk management.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today